Nick Ladziak, PharmD, BCACP, CDE


Effect of Changing COPD Triple-Therapy Inhaler Combinations on COPD Symptoms

April 10, 2019

Changing patients from an inhaled corticosteroid (ICS)/long-acting β agonist (LABA) inhaler and long-acting muscarinic agonist (LAMA) inhaler to a LAMA/LABA inhaler and a separate ICS inhaler did not appear to affect patient-reported chronic obstructive pulmonary disease (COPD) symptom scores.